Medtronic Expand Uro U.S. Clinical Trial Meets Safety And Effectiveness Primary Endpoints For Hugo™ Robotic-Assisted Surgery System

Reuters
27 Apr
April 26 (Reuters) - Medtronic PLC ::
*MEDTRONIC EXPAND URO U.S. CLINICAL TRIAL MEETS SAFETY AND EFFECTIVENESS PRIMARY ENDPOINTS FOR HUGO™ ROBOTIC-ASSISTED SURGERY SYSTEM
*MEDTRONIC PLC - SUBMITS HUGO RAS SYSTEM TO U.S. FDA
*MEDTRONIC PLC - STUDY ACHIEVES 98.5% SURGICAL SUCCESS RATE

((Reuters Investor Briefs; email: reutersinvestor.briefs@thomsonreuters.com))
Source Date/Time = 26-APR-202518:20:02.627 GMT

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10